ANKRD13D

Across TCGA pan-cancer cohorts, ANKRD13D RNA differs between tumor and matched normal tissue in 16 of 18 cancer types tested, making tumor–normal expression one of ANKRD13D’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where ANKRD13D RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ANKRD13D is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

COAD, KIRC, and HNSC are the cancer types where ANKRD13D tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ANKRD13D RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	IV	+1.382	<.001	11	view →
KIRC	Female	All	+0.600	<.001	11	view →
HNSC	Male	III,IV	+0.930	<.001	10	view →
LIHC	Female	II,III,IV	+1.380	<.001	9	view →
THCA	Female	II,III,IV	+0.707	<.001	9	view →
BLCA	Male	All	+1.035	<.001	7	view →
STAD	All	II,III,IV	+0.879	<.001	6	view →
BRCA	All	II,III,IV	+0.501	<.001	6	view →
KIRP	All	IV	+1.267	.029	5	view →
READ	Female	All	+0.973	<.001	5	view →
LUSC	Male	All	+0.480	<.001	5	view →
LUAD	All	All	+0.266	.002	5	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 16 lineages.

ANKRD13D–COAD

Open the COAD breakdown →